TelyRx Holdings Inc. is seeing a significant rise in its stock price, reflecting positive investor sentiment.
Today, TelyRx Holdings Inc. (TELY.TO) has increased by 4.67% to CA$2.69. This uptick comes as the company gains traction in the market, showcasing its potential for growth.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$68.34M
52W high
$4.25
52W low
$2.00
1W change
+3.46%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 123.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+123.0% Upside
Current Price
C$2.69
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
57.1%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
-16.8%
Annualized drift
90d Mean
C$2.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.64 | C$2.17 – C$3.21 |
| 60 trading days | C$2.58 | C$1.96 – C$3.41 |
| 90 trading days | C$2.53 | C$1.80 – C$3.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may interpret TelyRx's recent performance as a sign of confidence in its business direction and future financial results.
TelyRx's stock rises by 4.67% today
With a market capitalization of CA$68.3 million, TelyRx Holdings Inc. is showing resilience as it navigates a competitive market.
Bull case
The rise in stock price could indicate investor optimism about TelyRx's recent financial performance and growth potential, especially after its significant revenue increases in the last few quarters.
Bear case
Despite this positive movement, TelyRx is still operating at a loss, and any shift in market sentiment could quickly reverse these gains.
Advertisement
Positive Momentum in Financial Performance
TelyRx's recent financial results have shown a remarkable increase in revenue, reporting CA$42.9 million for the year ending December 31, 2025, compared to CA$9.5 million in 2024. This growth likely contributed to today's stock rise, as investors respond positively to the company's upward trend.
Market Sentiment and Future Outlook
The market's reaction to TelyRx's performance suggests growing confidence among investors. With a market cap of CA$68.3 million, TelyRx is well-positioned to take advantage of its recent successes. However, investors should remain cautious, as the company still faces challenges with profitability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
